Deka Bank Deutsche Girozentrale Ngm Biopharmaceuticals Inc Transaction History

Deka Bank Deutsche Girozentrale

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	BUY	$13.81 - $18.6 $31,763 - $42,780	2,300 Added 9.83%	25,700 $400,000
Q4 2021 Feb 02, 2022	SELL	$17.26 - $22.02 $409,062 - $521,874	-23,700 Reduced 50.32%	23,400 $401,000
Q1 2021 Apr 28, 2021	BUY	$24.99 - $31.93 $649,740 - $830,180	26,000 Added 123.22%	47,100 $1.3 Million
Q4 2020 Mar 12, 2021	SELL	$16.21 - $31.44 $17,831 - $34,584	-1,100 Reduced 4.95%	21,100 $654,000
Q3 2020 Oct 29, 2020	BUY	$15.59 - $19.97 $346,098 - $443,334	22,200 New	22,200 $351,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.